Literature DB >> 26550285

The clinical characteristic and risk of capsule incomplete and retention in Crohn's disease.

Juan Du1, Danmei Pan1, Panpan Ma1, Bingling Zhang1, Chunxiao Chen1.   

Abstract

OBJECTIVE: To evaluate capsule endoscopy in terms of incomplete examinations and capsule retentions, to describe the characteristic of these events and to find risk factors for these events.
METHODS: This retrospective and consecutive case-control study includes data of 204 capsule enteroscopy examinations in patients with Crohn's Disease, performed at the first hospital affiliated to zhejiang university medical school from June 2003 to April 2014.
RESULTS: The frequency of complete examinations was 56.9%. Male gender (OR=2.48, P=0.026), abdominal pain (OR=2.88, P=0.002), melena/bloody stools/OB+ (OR=3.34, P=0.009) were risk factors for an incomplete examination. Capsule retention occurred in 8.33% (n=17). The ratio of male and female was 12:5. While the average age of these patients was 42.2±16.2, and the average course of disease was 52.5±46.6 months. Of the seventeen cases of retained capsules, four patients chose to undergo surgery to remove the capsule for occurring symptoms of intestinal obstruction, spontaneous passage occurred in twelve patients after medical treatment, and one patient still have the capsule retained after 16 months of expectation. The longest capsule retained time in patients was four years. Risk factors for capsule retention was abdominal distention (OR=8.45, P=0.006).
CONCLUSIONS: The majority of capsule endoscopy retention develops into spontaneous passage after medical treatment. Therefore capsule endoscopy is considered a safe procedure, although obstructive symptoms and serious complications due to capsule retention can be found in patients with known Crohn's disease.

Entities:  

Keywords:  Crohn’s disease; capsule endoscopy; retention; risk factors

Year:  2015        PMID: 26550285      PMCID: PMC4612970     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

Review 1.  Endoscopic assessment of inflammatory bowel disease: colonoscopy/esophagogastroduodenoscopy.

Authors:  Grace Chan; David S Fefferman; Richard J Farrell
Journal:  Gastroenterol Clin North Am       Date:  2012-06       Impact factor: 3.806

2.  Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease.

Authors:  Stefan K Gölder; Andreas G Schreyer; Esther Endlicher; Stefan Feuerbach; Jürgen Schölmerich; Frank Kullmann; Johannes Seitz; Gerhard Rogler; Hans Herfarth
Journal:  Int J Colorectal Dis       Date:  2005-04-22       Impact factor: 2.571

3.  Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis.

Authors:  W A Voderholzer; J Beinhoelzl; P Rogalla; S Murrer; G Schachschal; H Lochs; M-A Ortner
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 4.  Capsule retention: a feared complication of wireless capsule endoscopy.

Authors:  Stefanos Karagiannis; Siegbert Faiss; Christos Mavrogiannis
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

5.  Videocapsule endoscopy versus barium contrast studies for the diagnosis of Crohn's disease recurrence involving the small intestine.

Authors:  Alan L Buchman; Frank H Miller; Anita Wallin; Aqeel A Chowdhry; Chul Ahn
Journal:  Am J Gastroenterol       Date:  2004-11       Impact factor: 10.864

6.  Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention.

Authors:  J H Cheon; Y-S Kim; I-S Lee; D K Chang; J-K Ryu; K J Lee; J-S Moon; C H Park; J-O Kim; K-N Shim; C H Choi; D Y Cheung; B I Jang; G-S Seo; H-J Chun; M-G Choi
Journal:  Endoscopy       Date:  2007-12       Impact factor: 10.093

7.  Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease.

Authors:  Cornelia Tillack; Julia Seiderer; Stephan Brand; Burkhard Göke; Maximilian F Reiser; Claus Schaefer; Helmut Diepolder; Thomas Ochsenkühn; Karin A Herrmann
Journal:  Inflamm Bowel Dis       Date:  2008-09       Impact factor: 5.325

8.  The longest duration of retention of a video capsule.

Authors:  Chris Harrington; Colin Rodgers
Journal:  BMJ Case Rep       Date:  2014-07-08

9.  Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease.

Authors:  William S Mow; Simon K Lo; Stephan R Targan; Marla C Dubinsky; Leo Treyzon; Maria T Abreu-Martin; Konstantinos A Papadakis; Eric A Vasiliauskas
Journal:  Clin Gastroenterol Hepatol       Date:  2004-01       Impact factor: 11.382

10.  When Crohn's disease is in remission, more patients complete capsule endoscopy study but less lesions are identified.

Authors:  Panagiotis Tsibouris; Apostolopoulos Periklis; Kalantzis Chrissostomos; Zalonis Antonios; Mavrogianni Panagiota; Vlachou Erasmia; Alexandrakis Georgios
Journal:  Saudi J Gastroenterol       Date:  2013 Mar-Apr       Impact factor: 2.485

View more
  4 in total

1.  [Mucosal healing in different intestinal segments in patients receiving infliximab treatment for small bowel Crohn's disease].

Authors:  Zhen-Hao Zhu; Chen Qiu; Ming Zhang; Zhao Chen; Cheng Xiang; Xin-Ying Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

Review 2.  Capsule retention: prevention, diagnosis and management.

Authors:  Emanuele Rondonotti
Journal:  Ann Transl Med       Date:  2017-05

3.  Adverse events of video capsule endoscopy over the past two decades: a systematic review and proportion meta-analysis.

Authors:  Yuan-Chen Wang; Jun Pan; Ya-Wei Liu; Feng-Yuan Sun; Yang-Yang Qian; Xi Jiang; Wen-Bin Zou; Ji Xia; Bin Jiang; Nan Ru; Jia-Hui Zhu; En-Qiang Linghu; Zhao-Shen Li; Zhuan Liao
Journal:  BMC Gastroenterol       Date:  2020-11-02       Impact factor: 3.067

4.  Initial experience of video capsule endoscopy at a tertiary center in Saudi Arabia.

Authors:  Abdulrahman Alkhormi; Mohammed Y Memon; Ahmad Elhafi; Mishal Aljohani; Abdullah Aljahdali; Adil Khatimi; Amer Rizvi; Khaled Shaban; Ghulam Yazdani; Mohammed Alnasser
Journal:  Saudi J Gastroenterol       Date:  2018 Nov-Dec       Impact factor: 2.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.